Despite the Covid-19 pandemic, life goes on.
And research on Parkinson's disease, which affects more than 6 million people worldwide, including around 200,000 in France, too.
At the beginning of the summer, the publication of a study by a Chinese team in the prestigious journal
Nature
raised the hopes of many patients.
"Several people have written to me to find out how to participate in a future clinical trial which is not yet on the agenda,"
reports Marie Fuzzati, research officer at the France Parkinson association.
To discover
OUR FILE - Tobacco: how to get out of it?
Read alsoAbnormal movements: when brain circuits malfunction
Chinese scientists have achieved a major feat: using a very advanced technique of genetic modification, they have succeeded in transforming astrocytes, cells located in the brain, into neurons capable of producing dopamine, the substance which is lacking in this disease. neurodegenerative.
But an important nuance must temper the hope aroused among patients: this progress has taken place…
This article is for subscribers only.
You have 82% left to discover.
Pushing back the limits of science is also freedom.
Keep reading your article for €0.99 for the first month
I ENJOY IT
Already subscribed?
Login
